BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16740776)

  • 1. Importance of the stress kinase p38alpha in mediating the direct cytotoxic effects of the thalidomide analogue, CPS49, in cancer cells and endothelial cells.
    Warfel NA; Lepper ER; Zhang C; Figg WD; Dennis PA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3502-9. PubMed ID: 16740776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice.
    Ng SS; MacPherson GR; Gütschow M; Eger K; Figg WD
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4192-7. PubMed ID: 15217957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs.
    Kumar S; Raje N; Hideshima T; Ishitsuka K; Roccaro A; Shiraishi N; Hamasaki M; Yasui H; Munshi NC; Richardson P; Figg WD; Anderson KC
    Leukemia; 2005 Jul; 19(7):1253-61. PubMed ID: 15858615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer.
    Zalazar F; De Luca P; Gardner K; Figg WD; Meiss R; Spallanzani RG; Vallecorsa P; Elguero B; Cotignola J; Vazquez E; De Siervi A
    Curr Pharm Biotechnol; 2015; 16(6):553-63. PubMed ID: 25860066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and flavopiridol.
    Ge Y; Byun JS; De Luca P; Gueron G; Yabe IM; Sadiq-Ali SG; Figg WD; Quintero J; Haggerty CM; Li QQ; De Siervi A; Gardner K
    Mol Pharmacol; 2008 Sep; 74(3):872-83. PubMed ID: 18556456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking p38/ERK crosstalk affects colorectal cancer growth by inducing apoptosis in vitro and in preclinical mouse models.
    Chiacchiera F; Grossi V; Cappellari M; Peserico A; Simonatto M; Germani A; Russo S; Moyer MP; Resta N; Murzilli S; Simone C
    Cancer Lett; 2012 Nov; 324(1):98-108. PubMed ID: 22579651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylinositol ether lipid analogues that inhibit AKT also independently activate the stress kinase, p38alpha, through MKK3/6-independent and -dependent mechanisms.
    Gills JJ; Castillo SS; Zhang C; Petukhov PA; Memmott RM; Hollingshead M; Warfel N; Han J; Kozikowski AP; Dennis PA
    J Biol Chem; 2007 Sep; 282(37):27020-27029. PubMed ID: 17631503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophil migration induced by mast cell chymase is mediated by extracellular signal-regulated kinase pathway.
    Terakawa M; Tomimori Y; Goto M; Hayashi Y; Oikawa S; Fukuda Y
    Biochem Biophys Res Commun; 2005 Jul; 332(4):969-75. PubMed ID: 15919053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft.
    Kraeber-Bodéré F; Bodet-Milin C; Niaudet C; Saï-Maurel C; Moreau A; Faivre-Chauvet A; Thomare P; Deleris G; Estieu-Gionnet K; Bikfalvi A; Barbet J; Paris F
    J Nucl Med; 2010 Apr; 51(4):624-31. PubMed ID: 20351352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis.
    Kunisch E; Gandesiri M; Fuhrmann R; Roth A; Winter R; Kinne RW
    Ann Rheum Dis; 2007 Aug; 66(8):1043-51. PubMed ID: 17223661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo.
    Navas TA; Nguyen AN; Hideshima T; Reddy M; Ma JY; Haghnazari E; Henson M; Stebbins EG; Kerr I; O'Young G; Kapoun AM; Chakravarty S; Mavunkel B; Perumattam J; Luedtke G; Dugar S; Medicherla S; Protter AA; Schreiner GF; Anderson KC; Higgins LS
    Leukemia; 2006 Jun; 20(6):1017-27. PubMed ID: 16617327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of mitogen-activated protein kinase (MAPK) in troglitazone-induced osteoblastic cell death.
    Jung JY; Yoo CI; Kim HT; Kwon CH; Park JY; Kim YK
    Toxicology; 2007 May; 234(1-2):73-82. PubMed ID: 17363128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappaB.
    Lin YC; Shun CT; Wu MS; Chen CC
    Clin Cancer Res; 2006 Dec; 12(23):7165-73. PubMed ID: 17145842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
    Ripple MO; Kalmadi S; Eastman A
    Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-content screening analysis of the p38 pathway: profiling of structurally related p38alpha kinase inhibitors using cell-based assays.
    Ross S; Chen T; Yu V; Tudor Y; Zhang D; Liu L; Tamayo N; Dominguez C; Powers D
    Assay Drug Dev Technol; 2006 Aug; 4(4):397-409. PubMed ID: 16945013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases.
    Muth F; Günther M; Bauer SM; Döring E; Fischer S; Maier J; Drückes P; Köppler J; Trappe J; Rothbauer U; Koch P; Laufer SA
    J Med Chem; 2015 Jan; 58(1):443-56. PubMed ID: 25475894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
    Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Shinagawa K; Teshima T; Ishimaru F; Ikeda K; Tanimoto M
    Oncology; 2004; 67(3-4):310-9. PubMed ID: 15557793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of ZD1839 (Iressa), a highly selective EGFR tyrosine kinase inhibitor, as a radiosensitiser in bile duct carcinoma cell lines.
    Miyata H; Sasaki T; Kuwahara K; Serikawa M; Chayama K
    Int J Oncol; 2006 Apr; 28(4):915-21. PubMed ID: 16525641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha induces the growth inhibition of human T-cell leukaemia line Jurkat through p38alpha and p38beta.
    Lee WH; Liu FH; Lee YL; Huang HM
    J Biochem; 2010 May; 147(5):645-50. PubMed ID: 20053787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.